XP CHEMISTRIES AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.122 SEK | -3.17% |
|
-40.20% | +2.52% |
| May. 17 | XP Chemistries AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 22 | XP Chemistries AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Sales 2022 | 1.06M 101K | Sales 2023 | 664K 63.47K | Capitalization | 11.12M 1.06M |
|---|---|---|---|---|---|
| Net income 2022 | -7M -669K | Net income 2023 | -8M -765K | EV / Sales 2022 | 0.87 x |
| Net cash position 2022 | 15.2M 1.45M | Net cash position 2023 | 7.83M 749K | EV / Sales 2023 | 4.96 x |
| P/E ratio 2022 |
-1.74
x | P/E ratio 2023 |
-0.46
x | Employees | 2 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 80.21% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.17% | ||
| 1 week | -40.20% | ||
| Current month | +1.67% | ||
| 1 month | +101.65% | ||
| 3 months | +234.25% | ||
| 6 months | -21.29% | ||
| Current year | +2.52% |
1 week
0.12
0.21
1 month
0.050.21
Current year
0.030.21
1 year
0.030.80
3 years
0.034.50
5 years
0.034.50
10 years
0.034.50
| Managers | Title | Age | Since |
|---|---|---|---|
Erik Nelsson
CEO | Chief Executive Officer | 41 | 20-12-31 |
Anders Frejdh
DFI | Director of Finance/CFO | 50 | 20-12-31 |
Shuang Zheng Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Armando Córdova
FOU | Founder | 54 | 14-12-31 |
Jonas Hafrén
BRD | Director/Board Member | 55 | 20-12-31 |
Samson Afewerki
FOU | Founder | 39 | 14-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-04 | 0.122 | -3.17% | 771 373 |
| 24-06-03 | 0.126 | +5.00% | 1,392,793 |
| 24-05-31 | 0.12 | -7.69% | 845,733 |
| 24-05-30 | 0.13 | -7.80% | 677,772 |
| 24-05-29 | 0.141 | -30.88% | 2,879,394 |
Delayed Quote Nasdaq Stockholm, June 04, 2024 at 11:19 am EDT
More quotes
XP Chemistries AB is a Sweden-based chemical, biological and pharmaceutical manufacturer. The Company has an international patent portfolio covering sustainable nature-inspired technologies optimal combinations of catalytic processes for the production of bio-based chemicals.
Sector
Pharmaceuticals
Calendar
2024-08-18
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +2.52% | 1.13M | |
| +41.89% | 748B | |
| +34.11% | 598B | |
| -6.61% | 356B | |
| +18.17% | 325B | |
| +3.84% | 283B | |
| +17.02% | 245B | |
| +9.26% | 211B | |
| -4.21% | 209B | |
| +1.77% | 166B |
- Stock Market
- Equities
- XPC Stock
